Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Three-Time Gold Medalist Misty May-Treanor Teams Up with Abreva to Knock Out Cold Sores this Cold and Flu Season



 Three-Time Gold Medalist Misty May-Treanor Teams Up with Abreva to Knock Out
                     Cold Sores this Cold and Flu Season

New survey reveals the majority of Americans don't have their facts straight
about cold sores

PR Newswire

PARSIPPANY, N.J., Dec. 6, 2012

PARSIPPANY, N.J., Dec. 6, 2012 /PRNewswire/ -- GlaxoSmithKline Consumer
Healthcare today announced it is teaming up with Misty May-Treanor, three-time
Olympic gold medalist in beach volleyball, in a campaign to knock out the
myths about cold sores. According to a new survey, the majority of Americans
(63 percent) cannot correctly distinguish between cold sore myths and facts,
and with cold and flu season approaching and cold sore triggers all around,
it's more important than ever to know how to fight cold sores fast.

(Photo: http://photos.prnewswire.com/prnh/20121206/NY24707)

The survey, conducted by Wakefield Research on behalf of Abreva^®, also
revealed that nearly 7 in 10 (68 percent) Americans value faster healing time
over lowest price when purchasing a medication. Abreva^® is clinically proven
to heal cold sores fast and is the number one over-the-counter cold sore
treatment recommended by pharmacists.

"I've gotten cold sores for as long as I can remember and they always seem to
pop up at the worst possible time. And for me, that was right in the middle of
the 2012 London Games," says Misty May-Treanor, professional beach volleyball
player and three-time Olympic gold medalist. "I have been using Abreva^® for
years, and I stick with it because it heals my cold sores fast. When I get a
cold sore, I don't tough it out, I knock it out with Abreva^®."

The survey revealed over half of respondents (52 percent) are unaware that
cold sores go through multiple stages of development before beginning to heal,
and one in two did not realize that if left untreated, cold sores can take up
to two weeks to heal.  Abreva^® heals cold sores much like a prescription
would but without the hassle. It penetrates deep to the root of a cold sore
and helps block the spread of the virus to healthy cells.

"Other 'look-alike' cold sore treatments claim to heal cold sores as fast as
Abreva^® and may even imitate the packaging, but Abreva^® is the only
over-the-counter medication approved by the FDA that is proven to shorten
healing time and duration of a cold sore," said Pam Marquess, Pharm.D,
pharmacist, pharmacy chain owner and GSK spokesperson. "We're heading into
prime cold sore season, with triggers like cold winter weather, cold/flu
season and even stress of the upcoming holidays upon us.  So if you're one of
the 80 million Americans who suffer from cold sores, be prepared to knock out
your cold sores fast with Abreva^®."

Abreva^® is available at retailers nationwide and comes with a risk free
guarantee. If you aren't completely satisfied with Abreva^® for any reason,
save your receipt and remaining product, and call 1-877-709-3539 to get your
money back. For more information about Abreva^®, please visit www.Abreva.com.

About Cold Sores
A cold sore is a blister that forms on or around the lips and is usually
caused by the Herpes Simplex Virus (HSV-1). HSV-1 usually affects the lips or
mouth but can spread to the eyes or genitals. Most cold sore sufferers aren't
exactly sure when they first encountered the virus because HSV-1 is usually
contracted early in childhood. ^  While it's likely that 90 percent of adults
have been infected by the cold sore virus, not everyone gets cold sore
outbreaks[.] Actually, only 20 percent to 40 percent of people will experience
cold sores.

About Abreva^®
Abreva is the only FDA-approved over-the-counter product to speed the healing
of cold sores. Abreva contains 10 percent docosanol.   

About GlaxoSmithKline Consumer Healthcare
GlaxoSmithKline Consumer Healthcare is one of the world's largest
over-the-counter consumer healthcare products companies. Its well-known brands
include Nicorette^® and NicoDerm^® CQ, the leading smoking cessation
products;  alli, the only FDA-OTC weight loss aid; as well as medicine cabinet
staples, Aquafresh^®, Sensodyne^®, Tums^®, and Breathe Right^®, all of which
are trademarks owned by and/or licensed to GlaxoSmithKline Group of Companies.

About GlaxoSmithKline^®
GlaxoSmithKline – one of the world's leading research-based pharmaceutical and
healthcare companies – is committed to improving the quality of human life by
enabling people to do more, feel better and live longer. For company
information visit: GSK.com.

Misty May-Treanor and Pam Marquess are paid spokespeople for Abreva^® but
their opinions are their own.  

Media Relations:           
           
                               Deborah Bolding
GSK Consumer Healthcare                                         (973) 889-2344
                               deborah.g.bolding@gsk.com
Edelman                        Catherine McCormack
                                                                (212) 819-4816
                               catherine.mccormack@edelman.com 

SOURCE GlaxoSmithKline

Website: http://www.Abreva.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement